December 2021 "Ottawa, Ontario, Canada, Nov. 30, 2021 -- Orion Biotechnology, a clinical stage company

June 2022 "Ottawa, Canada, May 10, 2022 — Orion Biotechnology Canada Ltd, a drug discovery and development Oliver Hartley, Orion’s Vice-President Drug Discovery, will present Orion’s novel technology for targeting His presentations will describe Orion’s drug discovery platform, one of the fastest drug discovery solutions Hartley will also present new data on Orion’s CCR2 antagonist, OB-004, demonstrating the ability of this

July 2022 "Orion Biotechnology and Peptilogics are pursuing AI-driven drug discovery to explore new functional

Oliver Hartley Oliver Hartley is VP for Drug Discovery at Orion Biotechnology . He is the inventor of OB-002 as well as the key technology underlying Orion’s discovery platform. Oliver Hartley on the web LinkedIn Orion Biotechnology Dr.

oncology research led me to pursue a BSc in Biology & Economics from Carleton University, and an MSc in Biotechnology In my role at Orion Biotechnology, I work at the intersection of science and business, which includes To that end, I'm grateful to be working alongside the very talented team at Orion who translate important

Timo De Groof studied Biochemistry and Biotechnology at the University of Ghent where he graduated in During his master's studies, he specialized in Biomedical Biotechnology and Structural Biology/Biochemistry